List of Tables
Table 1. Global Market Breast Cancer Therapeutics Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Breast Cancer Therapeutics Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Breast Cancer Therapeutics Drugs Market Size Share by Region (2018-2023)
Table 4. Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Breast Cancer Therapeutics Drugs Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Breast Cancer Therapeutics Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Breast Cancer Therapeutics Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2024-2029)
Table 11. North America Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Breast Cancer Therapeutics Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Breast Cancer Therapeutics Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2023)
Table 24. Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2024-2029)
Table 26. North America Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Therapeutics Drugs as of 2022)
Table 39. Date of Key Players Enter into Breast Cancer Therapeutics Drugs Market
Table 40. Global Breast Cancer Therapeutics Drugs Key Players Headquarters and Area Served
Table 41. Breast Cancer Therapeutics Drugs Product Solution and Service
Table 42. Global Breast Cancer Therapeutics Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer HealthCare Basic Information List
Table 45. Bayer HealthCare Description and Business Overview
Table 46. Bayer HealthCare Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Bayer HealthCare (2018-2023)
Table 48. Bayer HealthCare Recent Developments
Table 49. Eli Lily Basic Information List
Table 50. Eli Lily Description and Business Overview
Table 51. Eli Lily Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Eli Lily (2018-2023)
Table 53. Eli Lily Recent Developments
Table 54. Pfizer Basic Information List
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Pfizer (2018-2023)
Table 58. Pfizer Recent Developments
Table 59. Novartis Basic Information List
Table 60. Novartis Description and Business Overview
Table 61. Novartis Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Novartis (2018-2023)
Table 63. Novartis Recent Developments
Table 64. Eisai Basic Information List
Table 65. Eisai Description and Business Overview
Table 66. Eisai Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Eisai (2018-2023)
Table 68. Eisai Recent Developments
Table 69. Halozyme Therapeutics Basic Information List
Table 70. Halozyme Therapeutics Description and Business Overview
Table 71. Halozyme Therapeutics Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Halozyme Therapeutics (2018-2023)
Table 73. Halozyme Therapeutics Recent Developments
Table 74. Roche Basic Information List
Table 75. Roche Description and Business Overview
Table 76. Roche Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Roche (2018-2023)
Table 78. Roche Recent Developments
Table 79. Puma Biotechnology Basic Information List
Table 80. Puma Biotechnology Description and Business Overview
Table 81. Puma Biotechnology Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 82. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Puma Biotechnology (2018-2023)
Table 83. Puma Biotechnology Recent Developments
Table 84. Janssen Biotech Basic Information List
Table 85. Janssen Biotech Description and Business Overview
Table 86. Janssen Biotech Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 87. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Janssen Biotech (2018-2023)
Table 88. Janssen Biotech Recent Developments
Table 89. AbbVie Basic Information List
Table 90. AbbVie Description and Business Overview
Table 91. AbbVie Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 92. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of AbbVie (2018-2023)
Table 93. AbbVie Recent Developments
Table 94. BioMarin Basic Information List
Table 95. BioMarin Description and Business Overview
Table 96. BioMarin Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 97. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of BioMarin (2018-2023)
Table 98. BioMarin Recent Developments
Table 99. Array BioPharma Basic Information List
Table 100. Array BioPharma Description and Business Overview
Table 101. Array BioPharma Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 102. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Array BioPharma (2018-2023)
Table 103. Array BioPharma Recent Developments
Table 104. Merck Basic Information List
Table 105. Merck Description and Business Overview
Table 106. Merck Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 107. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Merck (2018-2023)
Table 108. Merck Recent Developments
Table 109. Syndax Basic Information List
Table 110. Syndax Description and Business Overview
Table 111. Syndax Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 112. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Syndax (2018-2023)
Table 113. Syndax Recent Developments
Table 114. MacroGenics Basic Information List
Table 115. MacroGenics Description and Business Overview
Table 116. MacroGenics Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 117. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of MacroGenics (2018-2023)
Table 118. MacroGenics Recent Developments
Table 119. ImmunoGen Basic Information List
Table 120. ImmunoGen Description and Business Overview
Table 121. ImmunoGen Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 122. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of ImmunoGen (2018-2023)
Table 123. ImmunoGen Recent Developments
Table 124. Santen Pharma Basic Information List
Table 125. Santen Pharma Description and Business Overview
Table 126. Santen Pharma Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 127. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Santen Pharma (2018-2023)
Table 128. Santen Pharma Recent Developments
Table 129. Celgene Basic Information List
Table 130. Celgene Description and Business Overview
Table 131. Celgene Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 132. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Celgene (2018-2023)
Table 133. Celgene Recent Developments
Table 134. Oncothyreon Basic Information List
Table 135. Oncothyreon Description and Business Overview
Table 136. Oncothyreon Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 137. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Oncothyreon (2018-2023)
Table 138. Oncothyreon Recent Developments
Table 139. AstraZeneca Basic Information List
Table 140. AstraZeneca Description and Business Overview
Table 141. AstraZeneca Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 142. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of AstraZeneca (2018-2023)
Table 143. AstraZeneca Recent Developments
Table 144. Sprint Bioscience Basic Information List
Table 145. Sprint Bioscience Description and Business Overview
Table 146. Sprint Bioscience Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 147. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Sprint Bioscience (2018-2023)
Table 148. Sprint Bioscience Recent Developments
Table 149. Genentech Basic Information List
Table 150. Genentech Description and Business Overview
Table 151. Genentech Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 152. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Genentech (2018-2023)
Table 153. Genentech Recent Developments
Table 154. Galena Biopharma Basic Information List
Table 155. Galena Biopharma Description and Business Overview
Table 156. Galena Biopharma Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 157. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Galena Biopharma (2018-2023)
Table 158. Galena Biopharma Recent Developments
Table 159. Lycera Basic Information List
Table 160. Lycera Description and Business Overview
Table 161. Lycera Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 162. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Lycera (2018-2023)
Table 163. Lycera Recent Developments
Table 164. CTI BioPharma Basic Information List
Table 165. CTI BioPharma Description and Business Overview
Table 166. CTI BioPharma Breast Cancer Therapeutics Drugs Products, Services and Solutions
Table 167. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of CTI BioPharma (2018-2023)
Table 168. CTI BioPharma Recent Developments
Table 169. North America Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 170. North America Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 171. Europe Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 172. Europe Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 173. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 174. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 175. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 176. Asia-Pacific Breast Cancer Therapeutics Drugs Market Share by Region (2018-2023)
Table 177. Asia-Pacific Breast Cancer Therapeutics Drugs Market Share by Region (2024-2029)
Table 178. Latin America Breast Cancer Therapeutics Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 179. Latin America Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 180. Latin America Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 181. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 182. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 183. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 184. Breast Cancer Therapeutics Drugs Market Trends
Table 185. Breast Cancer Therapeutics Drugs Market Drivers
Table 186. Breast Cancer Therapeutics Drugs Market Challenges
Table 187. Breast Cancer Therapeutics Drugs Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Therapeutics Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Breast Cancer Therapeutics Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Breast Cancer Therapeutics Drugs Market Share by Regions: 2022 VS 2029
Figure 4. Global Breast Cancer Therapeutics Drugs Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Mitotic Inhibitors
Figure 11. Global Mitotic Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Anti-Metabolites
Figure 13. Global Anti-Metabolites Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Hormone Receptor
Figure 15. Global Hormone Receptor Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Aromatase Inhibitors
Figure 17. Global Aromatase Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of HER2 Inhibitors
Figure 19. Global HER2 Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global Breast Cancer Therapeutics Drugs Market Size Share by Type: 2022 & 2029
Figure 21. North America Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)
Figure 22. Europe Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)
Figure 24. Latin America Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)
Figure 26. Phase I Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Phase II Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Phase III Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Global Breast Cancer Therapeutics Drugs Market Size Share by Application: 2022 & 2029
Figure 30. North America Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)
Figure 31. Europe Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)
Figure 32. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)
Figure 33. Latin America Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)
Figure 34. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)
Figure 35. Breast Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Breast Cancer Therapeutics Drugs Market Share in 2022
Figure 37. North America Breast Cancer Therapeutics Drugs Market Share by Country (2018-2029)
Figure 38. U.S. Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 39. Canada Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 40. Germany Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 41. France Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 42. U.K. Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 43. Italy Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 44. Russia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 45. Nordic Countries Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 46. Asia-Pacific Breast Cancer Therapeutics Drugs Market Share by Region (2018-2029)
Figure 47. China Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 48. Japan Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 49. South Korea Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 51. India Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 52. Australia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 53. Latin America Breast Cancer Therapeutics Drugs Market Share by Country (2018-2029)
Figure 54. Mexico Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 55. Brazil Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Breast Cancer Therapeutics Drugs Market Share by Country (2018-2029)
Figure 57. Turkey Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 59. UAE Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report